Nur Afiqah Mohamad Selected Research

Pure Alexia

10/2021

Transcranial direct current stimulation with multiple oral re-reading therapy for pure alexia without agraphia: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nur Afiqah Mohamad Research Topics

Disease

3	Macular Degeneration (Age-Related Maculopathy) 08/2018 - 01/2017
2	Migraine Disorders (Migraine) 01/2022 - 01/2021
1	Pain (Aches) 01/2022
1	Essential Hypertension 01/2022
1	Headache (Headaches) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Aphasia (Dysphasia) 10/2021
1	Stroke (Strokes) 10/2021
1	Pure Alexia 10/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2019
1	Pulmonary Arterial Hypertension 09/2018
1	Atrial Heart Septal Defects (Atrial Septal Defect) 09/2018
1	Retinal Diseases 01/2017
1	Eye Diseases (Eye Disease) 01/2017
1	Polypoidal Choroidal Vasculopathy 01/2017

Drug/Important Bio-Agent (IBA)

2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 10/2021
2	Ranibizumab (Lucentis)FDA Link 08/2018 - 01/2017
1	Endothelin-Converting EnzymesIBA 01/2022
1	Vasoconstrictor AgentsIBA 01/2022
1	Endothelin-1 (Endothelin 1)IBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2018
1	Serotonin (5 Hydroxytryptamine)IBA 09/2018
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 09/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2017
1	Retinaldehyde (Retinal)IBA 01/2017

Therapy/Procedure

3	Therapeutics 10/2021 - 01/2019
2	Transcranial Magnetic Stimulation 01/2022 - 01/2021
1	Transcranial Direct Current Stimulation 10/2021
1	Photochemotherapy (Photodynamic Therapy) 01/2017